Does Prestroke Antiplatelet Therapy Increase the Risk of Symptomatic Intracranial Hemorrhage in Patients Receiving Tissue Plasminogen Activator for Acute Ischemic Stroke? Editorial Article uri icon

Overview

publication date

  • April 29, 2017

Research

keywords

  • Brain Ischemia
  • Intracranial Hemorrhages
  • Platelet Aggregation Inhibitors
  • Risk Assessment
  • Tissue Plasminogen Activator

Identity

Scopus Document Identifier

  • 85018355572

Digital Object Identifier (DOI)

  • 10.1016/j.annemergmed.2017.03.013

PubMed ID

  • 28460862

Additional Document Info

volume

  • 71

issue

  • 3